Cargando…

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these, three highly pathogenic variants have emerged in the 21st century. The newest member of this group, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected at the end of 2019 in Hubei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Synowiec, Aleksandra, Szczepański, Artur, Barreto-Duran, Emilia, Lie, Laurensius Kevin, Pyrc, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849242/ https://www.ncbi.nlm.nih.gov/pubmed/33441314 http://dx.doi.org/10.1128/CMR.00133-20

Ejemplares similares

The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection
por: Barreto-Duran, Emilia, et al.
Publicado: (2022)

Identification of Cellular Factors Required for SARS-CoV-2 Replication
por: Synowiec, Aleksandra, et al.
Publicado: (2021)

Functional Severe Acute Respiratory Syndrome Coronavirus 2 Virus-Like Particles From Insect Cells
por: Naskalska, Antonina, et al.
Publicado: (2021)

HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
por: Milewska, Aleksandra, et al.
Publicado: (2021)

Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
por: Milewska, Aleksandra, et al.
Publicado: (2020)

Reversible rearrangement of the cellular cytoskeleton: A key to the broad-spectrum antiviral activity of novel amphiphilic polymers()
por: Dabrowska, Agnieszka, et al.
Publicado: (2023)

Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells
por: Szczepanski, Artur, et al.
Publicado: (2018)

Novel coronavirus-like particles targeting cells lining the respiratory tract
por: Naskalska, Antonina, et al.
Publicado: (2018)

SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis
por: Lenart, Marzena, et al.
Publicado: (2023)

Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
por: Naskalska, Antonina, et al.
Publicado: (2019)

Canine Respiratory Coronavirus, Bovine Coronavirus, and Human Coronavirus OC43: Receptors and Attachment Factors
por: Szczepanski, Artur, et al.
Publicado: (2019)

SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis
por: Szlachcic, Wojciech J., et al.
Publicado: (2022)

Early events during human coronavirus OC43 entry to the cell
por: Owczarek, Katarzyna, et al.
Publicado: (2018)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: O’Leary, Valerie Bríd, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronaviridae)
por: Peiris, Malik
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth
por: Hermesch, Amy C., et al.
Publicado: (2020)

SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
por: Pyrć, Krzysztof, et al.
Publicado: (2021)

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
por: Napolitano, Valeria, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
por: Feng, Wei, et al.
Publicado: (2020)

Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
por: Maveddat, Ashley, et al.
Publicado: (2020)

JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Inglis, Timothy J. J., et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)
por: McFee, R.B.
Publicado: (2020)

Pseudanabaena galeata CCNP1313—Biological Activity and Peptides Production
por: Cegłowska, Marta, et al.
Publicado: (2022)

Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle
por: Popowicz, Grzegorz Maria, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
por: Tong, Tommy R.
Publicado: (2006)

The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
por: Pancer, Katarzyna, et al.
Publicado: (2020)

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
por: Salajegheh Tazerji, Sina, et al.
Publicado: (2020)

Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
por: Byard, Roger W., et al.
Publicado: (2020)

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry
por: Wandernoth, Petra, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
por: Steenblock, Charlotte, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
por: De Felice, Fernanda G., et al.
Publicado: (2020)

The Aerosolization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Phase I
por: Ayuso, Sullivan A., et al.
Publicado: (2022)

Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system
por: Wang, Nengzhuang, et al.
Publicado: (2021)

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
por: Tulimilli, SubbaRao V., et al.
Publicado: (2022)

Battle at the entrance gate: CIITA as a weapon to prevent the internalization of SARS-CoV-2 and Ebola viruses
por: Butowt, Rafal, et al.
Publicado: (2020)

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Noor, Rashed
Publicado: (2021)

Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
por: Abu-Raddad, Laith J, et al.
Publicado: (2021)

l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells
por: Sancineto, Luca, et al.
Publicado: (2021)

Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
por: Khan, Suliman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8t4bimll9sj73ecdas9ft1amms